MCDA framework for Oncologic Treatments

March 11th, 2020|

Development of a Multicriteria Decision Analysis Framework for Evaluating and Positioning Oncologic Treatments in Clinical Practice Avaliable at: [...]

MCDA Hemlibra® in haemophilia A with inhibitors

October 8th, 2019|

Determining the value contribution of emicizumab (Hemlibra®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis Avaliable at: https://jou [...]

MCDA framework for Ophan Drugs in Spain

August 8th, 2019|

Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain Avaliable at: [...]

MCDA in the Catalan Health Service for Orphan Drugs

June 27th, 2019|

Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut) Avaliable at: [...]

Patient-Reported Outcomes in Achondroplasia

May 19th, 2019|

Cross-cultural selection and validation of instruments to assess patient-reported outcomes in children and adolescents with achondroplasia Avaliable at: [...]

Load More Posts

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the aforementioned cookies and the acceptance of our cookies policy, Click on the link for more information. ACEPTAR

Aviso de cookies